These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5979056)

  • 21. Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures? Interrupted time series analysis of cost, volume and cost per volume trends in Sweden 1986-2002.
    Andersson K; Petzold MG; Sonesson C; Lönnroth K; Carlsten A
    Health Policy; 2006 Dec; 79(2-3):231-43. PubMed ID: 16473436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmaceutical care of patients with diabetes mellitus and its relationship to clinical pharmacy].
    Vlcek J; Malý J; Dosedel M
    Vnitr Lek; 2009 Apr; 55(4):384-8. PubMed ID: 19449755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The link between publicly funded health care and compulsory licensing.
    Hollis A
    CMAJ; 2002 Oct; 167(7):765-6. PubMed ID: 12389839
    [No Abstract]   [Full Text] [Related]  

  • 24. The supply of medicines in Poland.
    Valentine L
    Survey (Lond); 1987; 29(4):108-12. PubMed ID: 11618192
    [No Abstract]   [Full Text] [Related]  

  • 25. [Better benefits for the aged and the sick].
    Lakartidningen; 1966 Nov; 63(46):4422-3. PubMed ID: 5979942
    [No Abstract]   [Full Text] [Related]  

  • 26. Decentralized responsibility for costs of outpatient prescription pharmaceuticals in Sweden. Assessment of models for decentralized financing of subsidies from a management perspective.
    Bergström G; Karlberg I
    Health Policy; 2007 May; 81(2-3):358-67. PubMed ID: 16942815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mercury-containing drugs. Investigation by the State Pharmaceutical Laboratory of possible harmful effects from mercury-containing drugs].
    Rosén A
    Lakartidningen; 1966 Nov; 63():Suppl 2:51-3. PubMed ID: 5979928
    [No Abstract]   [Full Text] [Related]  

  • 28. [Problems of drug safety].
    Liljestrand A
    Nord Med; 1967 Nov; 78(47):1535-9. PubMed ID: 6075272
    [No Abstract]   [Full Text] [Related]  

  • 29. The policy of medicines and its role in the supply of socialist public health.
    Simon Kiss G
    Sante Publique (Bucur); 1983; 26(2):135-46. PubMed ID: 6665684
    [No Abstract]   [Full Text] [Related]  

  • 30. [Drug quality control--the contribution of pharmacy to drug safety. The historical development of the Working Group for Drug Control-Pharmaceutical Analysis of the German Pharmaceutical Society. 2].
    Göber B; Kny L; Langner A
    Pharm Unserer Zeit; 2000 Jul; 29(4):237-42. PubMed ID: 10969536
    [No Abstract]   [Full Text] [Related]  

  • 31. Reimbursement and clinical guidance for pharmaceuticals in Sweden: do health-economic evaluations support decision making?
    Anell A; Persson U
    Eur J Health Econ; 2005 Sep; 6(3):274-9. PubMed ID: 15968561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dr Knock's return in reality: "Everyone is sick--but not everyone is aware about that!"].
    Melander A; Järhult B; Lindahl SO
    Lakartidningen; 2004 Jun; 101(23):2031. PubMed ID: 15232844
    [No Abstract]   [Full Text] [Related]  

  • 33. [Consumers' drug information].
    Sven Farm Tidskr; 1965 Nov; 69(31):905-8. PubMed ID: 5868453
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug and health administration combine].
    Sven Farm Tidskr; 1965 Sep; 69(25):726-31. PubMed ID: 5868436
    [No Abstract]   [Full Text] [Related]  

  • 35. Medicines management.
    Griffiths M
    Nurs Stand; 2008 May 14-20; 22(36):28. PubMed ID: 18543721
    [No Abstract]   [Full Text] [Related]  

  • 36. [Some aspects on drug safety control].
    Pekkarienen A
    Nord Med; 1967 Nov; 78(47):1539-42. PubMed ID: 6075273
    [No Abstract]   [Full Text] [Related]  

  • 37. ["You don't need to look in the bag". Social Welfare Board will close the debate on pharmaceutical drug dosages].
    Norling H
    Vardfacket; 1997 Mar; 21(3):4-6. PubMed ID: 9456868
    [No Abstract]   [Full Text] [Related]  

  • 38. [Position paper of the German Pharmaceutical Society on drug specifications].
    Pharm Unserer Zeit; 2002; 31(5):501-3. PubMed ID: 12369169
    [No Abstract]   [Full Text] [Related]  

  • 39. [Quality control of drugs--the contribution of pharmacy to drug safety standards. The historical development of the working group on drug quality control--pharmaceutical analysis of the German Pharmaceutical Society. 1].
    Göber B; Kny L; Langner A
    Pharm Unserer Zeit; 2000 May; 29(3):174-82. PubMed ID: 10881602
    [No Abstract]   [Full Text] [Related]  

  • 40. [Position paper of the Working Group on Drug Control-Pharmaceutical Analysis of the German Pharmaceutical Society to establish principles for criteria of acceptance].
    Wätzig H; Ermer J
    Pharm Unserer Zeit; 2003; 32(3):254-6. PubMed ID: 12784547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.